BNIP3 and sarcopenia: In order to assess whether BNIP3 expression levels were associated with healthy aging and probability of developing sarcopenia, we used the Charlson comorbidity index (CCI), a method that categorizes comorbidities of patients based on the International Classification of Diseases, which has been associated with skeletal muscle mass and physical performance in aged individuals (Gong et al., 2019).